Meridian Bioscience, Inc. announced the launch of TruQuick(TM), a comprehensive point-of-care product menu of rapid tests for the diagnosis of tropical, infectious, sexually transmitted, respiratory, gastrointestinal, cancer, and cardiac diseases. This product menu will enable Meridian to rapidly expand its product portfolio of high value rapid tests for its commercial operations in Asia Pacific and other emerging markets around the world.
TruQuick(TM) is a qualitative lateral flow chromatographic immunoassay menu of over 60 products. TruQuick(TM) rapid tests can aid in the diagnosis of infectious pathogens and other important acute diseases in 10 to 20 minutes with high levels of accuracy and speed to results. Meridian understands the clinical testing requirements in Asia and other emerging markets for speed, sensitivity, specificity, and breadth of product line.
Lourdes Weltzien, Ph.D., President of Meridian Asia Pacific commented, "We are excited to launch the new TruQuick(TM) brand of rapid tests for the rapidly growing point-of-care market in the Asia Pacific region. As for other regions of the world, Meridian will quickly introduce the TruQuick(TM) brand of products based on regional demands and registration priorities."
Richard L. Eberly, President, Chief Commercial Officer, stated, "One of Meridian`s key strategies over the past few years has been to expand our global commercial operations in emerging markets around the world. Meridian has expanded operations in China, Singapore, Australia, Africa, and South America. The product portfolio for these emerging markets is rapidly expanding. We are delighted to add the TruQuick(TM) brand of rapid point-of-care products to our commercial channels in these important markets."
TruQuick(TM) is a qualitative lateral flow chromatographic immunoassay menu of over 60 products. TruQuick(TM) rapid tests can aid in the diagnosis of infectious pathogens and other important acute diseases in 10 to 20 minutes with high levels of accuracy and speed to results. Meridian understands the clinical testing requirements in Asia and other emerging markets for speed, sensitivity, specificity, and breadth of product line.
Lourdes Weltzien, Ph.D., President of Meridian Asia Pacific commented, "We are excited to launch the new TruQuick(TM) brand of rapid tests for the rapidly growing point-of-care market in the Asia Pacific region. As for other regions of the world, Meridian will quickly introduce the TruQuick(TM) brand of products based on regional demands and registration priorities."
Richard L. Eberly, President, Chief Commercial Officer, stated, "One of Meridian`s key strategies over the past few years has been to expand our global commercial operations in emerging markets around the world. Meridian has expanded operations in China, Singapore, Australia, Africa, and South America. The product portfolio for these emerging markets is rapidly expanding. We are delighted to add the TruQuick(TM) brand of rapid point-of-care products to our commercial channels in these important markets."